gmittaldelveinsight's articles

Janus kinase (JAK) Inhibitors pipeline constitutes 40+ key companies continuously working towards developing 45+ Janus kinase (JAK) Inhibitors treatment therapies, analyzes DelveInsight   Janus kinase (JAK) Inhibitors are the latest drug class of disease-modifying medication to emerge for the treatment of rheumatoid arthritis (RA). They are a small molecule-targeted treatment and are the first oral […]
Programmed Cell Death Protein 1 (PD-1) plays a vital role in inhibiting immune responses and promoting self-tolerance through modulating the activity of T-cells, activating apoptosis of antigen-specific T cells and inhibiting apoptosis of regulatory T cells. Programmed Cell Death Ligand 1 (PD-L1) is a trans-membrane protein that is considered to be a co-inhibitory factor of […]
The oncolytic viruses (OVs) are organisms able to identify, infect, and lyse different cells in the tumor environment, aiming to stabilize and decrease the tumor progression. They can present a natural tropism to the cancer cells or be oriented genetically to identify specific targets. Several OVs are being studied as a potential treatment for cancer […]
Microbiome pipeline constitutes 130+ key companies continuously working towards developing 200+ Microbiome treatment therapies, analyzes DelveInsight Microbiome is the collection of all microbes, such as bacteria, fungi, viruses, and their genes, that naturally live on our bodies and inside us. Although microbes are so small that they require a microscope to see them, they contribute […]
Introduction Molecular diagnostics (MDx) is the application of the molecular biology technique used in the study of human diseases, including infectious diseases, inherited conditions as well as cancer. The research focuses on genomic and proteomic analysis to identify the disease biomarkers, creating better diagnostics that ultimately find new treatments and potential cures. The techniques used […]
To co-construct business transformation, DelveInsight assists clients through a multidimensional, purposeful, and credible market analysis that accelerates business growth and overcomes challenges via profound healthcare domain expertise with data-to-insights capabilities. DelveInsight has expertise in healthcare business consulting, with the ability to take a deep dive into business problems and emerge with actionable insights, enabling business […]
CRISPR technology or CRISPR/Cas9 technology is a genome-editing tool derived from the bacterial defense system against viruses and plasmids. The system comprises the Cas9 nuclease enzyme to create site-directed dsDNA (double-stranded DNA) break and a guide RNA, which is a predesigned 20 bp long RNA sequence within a more extended RNA scaffold. This sequence guides […]
Stem Cells therapies and CRISPR gene-editing are not new. Having able to grow the desired cells and manipulate the genome system have proved to be the most important breakthrough so far. We all are aware of the fact that Embryos possess the potential to produce pluripotent cells that researchers experiment on to produce Regenerative Medicine. But that results in the killing of […]
The ability of CRISPR to change an organism’s DNA has lead researchers, particularly from Nigeria to use the tool to perform diagnostic tests. Since CRISPR therapeutics is all about targeting the genome-specific sequence, the test is believed to pinpoint the exact viral strain circulating. The recent epidemic of Lassa fever in Nigeria resulted in researchers to weigh the probability of using a diagnostic test based on gene editing tool CRISPR. The […]
The researchers announced that they had edited human embryos to repair a damaged gene that can lead to heart failure, but critics raised their eyebrows. Now, new evidence confirms that the gene editing was successful, said by reproductive and developmental biologist Shoukhrat Mitalipov of Oregon Health & Science University in Portland, and colleagues report in “Nature” that all of the conclusions were basically […]
Six months ago, Chinese researchers reported that an enzyme called NgAgo could be used to edit mammalian genes – and that it might be more accurate and more versatile than the popular CRISPR-Cas9 gene-editing technique. But almost immediately, other scientists complained on internet forums that they could not replicate the experiment. Now, a paper with […]
  CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), a gene-editing technology, has set a record by reaching clinics from the research laboratory in a very short time, as NIH’s Recombinant DNA Advisory Committee has approved the first clinical trial of the technology in the U.S. for coming June. The trial investigators have proposed to exploit this technology […]
Developmental and Epileptic Encephalopathy (DEE) is a term used to describe a category of severe epilepsies that are marked by severe developmental delays or possibly the loss of developmental skills in addition to seizures that are frequently drug-resistant. Cognitive processes are significantly impacted by seizures, interictal epileptiform activity, and the neurobiological basis of epilepsy in […]
The most prevalent bacterial sexually transmitted infection worldwide is chlamydia. Infections with Chlamydia are asymptomatic in 50–88% of men and women, and 46% of infections spontaneously disappear after a year. Men can get epididymitis and epididymo-orchitis from persistent chlamydia infection, while women can develop pelvic inflammatory illness, ectopic pregnancy, and tubal infertility. Chlamydia infection can […]
Obesity is a chronic health problem that causes the body to accumulate abnormally large amounts of fat or adipose tissue, which is dangerous for one's health. Between calories consumed and calories expended, there is an imbalance. Heredity, a sedentary lifestyle, excessive fat, sugar consumption (energy-dense meals), certain drugs, and endocrine problems are the reasons for […]
Competitive intelligence tools can help analyze data and produce insightful analyses that can be used to find R&D synergies between partner companies, comprehend operational metrics that are common to both parties, or assess the risks associated with any kind of agreement.   Improved Research and Development: By keeping track of industry failures, pharmaceutical competitive intelligence […]

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe